Literature DB >> 20460142

Deficient inhibition of return in chronic but not first-episode patients with schizophrenia.

Dengtang Liu1, Xiaoduo Fan, Yan Wang, Zhiliang Yang, Kaiming Zhuo, Zhenhua Song, Yan Wu, Chunbo Li, Jijun Wang, Yifeng Xu.   

Abstract

BACKGROUND: Inhibition of return (IOR) has been tested in patients with schizophrenia with contradictory results. Some studies indicated that patients with schizophrenia have normal levels of IOR; however, other studies reported delayed or blunted IOR. Inconsistency in findings might be due to differences across studies in relevant aspects associated with disease, such as heterogeneity of the disorder, different medications, onset and severity of the illness. The present study was to explore different patterns of IOR in antipsychotic medication free first-episode schizophrenia and chronic schizophrenia.
METHODS: Forty two patients with first-episode schizophrenia, 44 patients with chronic schizophrenia, and 38 healthy controls were included in the study. All subjects went through a covert orienting of attention task with seven stimulus onset asynchrony (SOA) intervals (400 ms, 500 ms, 600 ms, 700 ms, 800 ms, 1200 ms and 1500 ms).
RESULTS: Compared with healthy controls, the magnitude and onset of IOR in first-episode patients with schizophrenia were intact. However, in patients with chronic schizophrenia, there was an attenuated cuing effect especially at SOA 700 ms; in addition, there was a robust IOR until at SOAs 800 ms or above. Moreover, the illness duration and the number of psychotic episodes were significantly correlated with the validity effect at SOAs 400 ms and 600 ms.
CONCLUSION: Our study suggests that deficient IOR presents in chronic but not in first-episode patients with schizophrenia. IOR deficit in schizophrenia may begin during the course of illness and deteriorate over the course of illness. Our findings are consistent with the neurodegenerative model of schizophrenia. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20460142     DOI: 10.1016/j.pnpbp.2010.05.002

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  3 in total

1.  Auditory verbal hallucinations and the interhemispheric auditory pathway in chronic schizophrenia.

Authors:  Marlene Wigand; Marek Kubicki; Christian Clemm von Hohenberg; Gregor Leicht; Susanne Karch; Ryan Eckbo; Paula E Pelavin; Kathryn Hawley; Dan Rujescu; Sylvain Bouix; Martha E Shenton; Christoph Mulert
Journal:  World J Biol Psychiatry       Date:  2014-09-16       Impact factor: 4.132

2.  Neural correlates of the preserved inhibition of return in schizophrenia.

Authors:  Yingying Tang; Yan Li; Kaiming Zhuo; Yan Wang; Liwei Liao; Zhenhua Song; Hui Li; Xiaoduo Fan; Donald C Goff; Jijun Wang; Yifeng Xu; Dengtang Liu
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 3.  Research progress in China on the assessment of cognitive function in schizophrenia.

Authors:  Dengtang Liu; Yingchan Wang; Yifeng Xu; Kaida Jiang
Journal:  Shanghai Arch Psychiatry       Date:  2013-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.